In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 731-736

  Venkateswarlu, K ^a   Denning, D W ^b   Kelly, S L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE; STEROL;

ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA KRUSEI; CONTROLLED STUDY; NONHUMAN; SPECIES DIFFERENCE; STEROL SYNTHESIS;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CANDIDA; CARBON MONOXIDE; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE; TIME FACTORS; TRIAZOLES;

EID: 0030849268     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.731     Document Type: Article

References (27)

1. Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T. et al. & The National Nosocomial Infections Surveillance System. (1991). Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Americal Journal of Medicine 91, Suppl. 3B, 86S-9S.
2. Beck-Sague, C. & Jarvis, W. R. (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. Journal of Infectious Diseases 167, 1247-51.
3. Baily, G. G., Perry, F. M., Denning, D. W. & Mandal, B. K. (1994). Fluconazole-resistant candidosis in an HIV cohort. AIDS 8, 787-92.
4. Troke, P. (1993). In vitro and experimental in vivo activities of fluconazole against some fungi causing cutaneous mycoses. In Cutaneous Antifungal Agents (Rippon, J. W. & Fromtling, R. A. Eds), pp. 199-214. Marcel Dekker, New York, NY.
5. Karyotakis, N. C. & Anaissie, E. J. (1994). The new antifungal azoles: fluconazole and itraconazole. Current Opinion in Infectious Diseases 7, 658-66.
6. Marichal, P., Gorrens, J., Coene, M. C., Le Jeune, L. & Vanden Bossche, H. (1995). Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses 38, 111-7.
7. Ballard, S. A., Ellis, S. W., Kelly, S. L. & Troke, P. F. (1990). A novel method for studying ergosterol biosynthesis by cell-free preparation of Aspergillus fumigatus and its inhibition by azole anti- fungal agents. Journal of Medical and Veterinary Mycology 28, 335-44.
8. Wardle, H. M., Law, D., Moore, C. B., Mason, C. & Denning, D. W. (1995). In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrobial Agents and Chemotherapy 39, 868-71.
9. Joseph-Home, T., Hollomon, D., Manning, N. & Kelly, S. L (1996). Investigation of the sterol composition and azole resistance in field isolates of Septoria tritici. Applied and Environmental Microbiology 62, 184-90.
10. Quail, M. A., Arnoldi, A., Moore, D. J., Goosey, M. W. & Kelly, S. L. (1993). Ketoconazole-mediated growth inhibition in Botrytis cinerea and Saccharomyces cerevisiae. Phytochemistry 32, 273-80.
11. Howell, S. A., Mallet, A. I. & Noble, W. C. (1990). A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains. Journal of Applied Bacteriology 69, 692-6.
12. Venkateswarlu, K., Denning, D. W., Manning, N. J. & Kelly, S. L. (1995). Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiology Letters 131, 337-41.
13. Venkateswarlu, K., Denning, D. W., Manning, N. J. & Kelly, S. L. (1996). Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrobial Agents and Chemotherapy 40, 1382-86.
14. Omura, T. & Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. Journal of Biological Chemistry 239, 2370-8.
15. Ballard, S. A., Kelly, S. L., Ellis, S. W. & Troke, P. F. (1990). Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. Journal of Medical and Veterinary Mycology 28, 327-34.
16. Jefcoate, C. R. (1978). Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods in Enzymology 52, 258-79.
17. Black, S. D. & Coon, M. J. (1987). P-450 cytochromes: structure and function. Advances in Enzymology and Related Areas of Molecular Biology 60, 35-87.
18. Joseph-Home, T., Hollomon, D., Loeffler, R. S. T. & Kelly, S. L. (1995). Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 39, 1526-9.
19. Nes, W. D., Janssen, G. G., Crumley, F. G., Kalinowska, M. & Akihisa, T. (1993). The structural requirements of sterols for membrane function in Saccharomyces cerevisiae. Archives of Biochemistry and Biophysics 300, 724-33.
20. Vanden Bossche, H., Marichal, P., Gorrens, J., Bellens, D., Verhoeven, H., Coene, M. C. et al. (1987). Interaction of azole derivatives with cytochrome P-450 isozymes in yeast, fungi, plants and mammalian cells. Pesticide Science 21, 289-306.
21. Yoshida, Y. & Aoyama, Y. (1984). Yeast cytochrome P-450 catalyzing lanosterol 14α-demethylation. 1. Purification and spectral properties. Journal of Biological Chemistry 259, 1655-60.
22. Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V. & Adams, D. J. (1989). Purification and properties of cytochrome P-450-dependent 14α-sterol demethylase from Candida albicans. Biochemical Journal 263, 573-9.
23. 22-desaturation in ergosterol biosynthesis of yeast. Agricultural and Biological Chemistry 51, 1349-54.
24. Kelly, S. L., Lamb, D. C., Corran, A. J., Baldwin, B. C., Parks, L. W. & Kelly, D. E. (1995). Purification and reconstitution of activity of Saccharomyces cerevisiae P450-61, a sterol delta(22)- desaturase. FEBS Letters 377, 217-20.
25. Skaggs, B. A., Alexander, J. F., Pierson, C. A., Schweitzer, K. S., Chun, K. T., Koegel, C. et al. (1996). Cloning and characterization of the Saccharomyces cerevisiae C-22 sterol desaturase gene, encoding a second cytochrome P-450 involved in ergosterol biosynthesis. Gene 169, 105-9.
26. Smith, K. E., Ahmed, F., Williams, R. A. D. & Kelly, S. L. (1994). Microbial transformations of steroids - VIII. Transformation of progesterone by whole cells and microsomes of Aspergillius fumigatus. Journal of Steroid Biochemistry and Molecular Biology 49, 93-100.
27. Venkateswarlu, K., Marsh, R. M., Faber, B. & Kelly, S. L. (1996). Investigation of cytochrome P450 mediated benzo(a)pyrene hydroxylation in Aspergillus fumigatus. Journal of Chemical Technology and Biotechnology 66, 139-44.